Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

EVIDENCE OF SEX, RACE, AND ETHNICITY DISPARITIES WITH NEW DRUGS: DRUG FORMULARY MANAGEMENT AND UTILIZATION


Date: Dec 18, 2021 07:00 PM - 08:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Feb 12, 2022 09:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Nurses
  • Healthcare Professionals

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

Clinical Pharmacy Associates (CPA)

 

 

 

Objectives

  • Review evidence from available newer clinical studies for FDA approved drugs in 2019-2021 regarding participation of underrepresented groups based on sex, race and ethnicity.
  • Recognize major trends in participation by underrepresented groups in clinical studies used to gain drug approval by the FDA.
  • Identify at least 2 reasons underrepresentation of populations in clinical trials exist in the US and recommend at least one action that can be taken to address this disparity.
  • Discuss the potential impact of underrepresentation of groups in new drug studies on our understanding of their safety, efficacy and use in clinical practice.
  • Given a case of the newer antiretroviral drugs, Cabenuva and Vocabrio participate in a formulary review discussion about the products evidence regarding sex, race, and ethnicity.

Speaker(s)/Author(s)

Dr. Christopher Keeys, Pharm.D.,BCPS, Pharm.D., BCPS
President, Clinical Pharmacy Associates, Inc.

Activity Number

0010-9999-21-073-L01-P
Date: 12/18/21
Time: 07:00 PM - 08:00 PM

CE Hours

1.00